Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 3, 1999, Pages 737-743

  Holz, Frank G ^a   Schütt, Florian ^a   Kopitz, Jürgen ^a   Eldred, Graig E ^b   Kruse, Friedrich E ^a   Völcker, Hans E ^a   Cantz, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b University of Heidelbergm ^*

Author keywords

[No Author keywords available]

Indexed keywords

LIPOFUSCIN;

ARTICLE; CELL COMPARTMENTALIZATION; DRUG ACCUMULATION; ENDOCYTOSIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; LYSOSOME MEMBRANE; PHAGOCYTOSIS; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; RETINA DEGENERATION; RETINA MACULA AGE RELATED DEGENERATION;

ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOSAMINOGLYCANS; HUMANS; HYDROGEN-ION CONCENTRATION; LIPOFUSCIN; LIPOPROTEINS, LDL; LYSOSOMES; MIDDLE AGED; PIGMENT EPITHELIUM OF EYE; RETINAL PIGMENTS; RETINOIDS; SUBCELLULAR FRACTIONS;

EID: 0033017053     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Yin D. Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radic Biol Med. 1996;21:871-888.
2. Boulton M, McKechnie NM, Breda J, Bayly M, Marshall J. The formation of autofluorescent granules in cultured human RPE. Invest Ophthalmol Vis Sci. 1989;30:83-89.
3. Katz ML, Gao CL, Rice LM. Formation of lipofuscin-like fluorophores by reaction of retinal with photoreceptor outer segments and liposomes. Mech Ageing Dev. 1996;92:159-174.
4. Weingeist TA, Kobrin JL, Watz KE. Histopathology of Best's macular dystrophy. Arch Ophthalmol. 19821;100:1108-1114.
5. Frangieh GT, Green WR, Fine SL. A histopathologic study of Best's macular dystrophy. Arch Ophthalmol. 1982;100:1115-1121.
6. Eagle RC, Lucier AC, Bernadino VB, Janoff M. Retinal pigment epithelial abnormalities in fundus flavimaculatus; a light and electron microscopical study. Ophthalmology. 1980;87:1189-2000.
7. Steinmetz RL, Garner A, Maguire JI, Bird AC. Histopathology of incipient fundus flavimaculatus. Ophthalmology. 1991;98:953-956.
8. Bird AC. Age-related macular disease. Br J Ophthalmol. 1996;80: 1-2.
9. Boulton M, Marshall J. Effects of increasing numbers of phagocytic inclusions on human retinal pigment epithelial cells in culture: a model for aging. Br J Ophthalmol. 1986;70:808-815.
10. Eldred GE, Katz ML. The lipid peroxidation theory of lipofuscinogenesis cannot yet be confirmed. Free Radic Biol Med. 1991;10: 445-447.
11. Katz ML. Incomplete proteolysis may contribute to lipofuscin accumulation in the retinal pigment epithelium. Adv Exp Med Biol. 1989;266:109-116.
12. Kennedy CJ, Rakoczy PE, Constable IJ. Lipofuscin of the retinal pigment epithelium: a review. Eye. 1995;9:763-771.
13. Dorey CK, Wu G, Ebenstein D, Garsd A, Weiter JJ. Cell loss in the aging retina: relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci. 1989;30:1691-1699.
14. Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ. In vivo fluorescence of the ocular fundus exhibits RPE lipofuscin characteristics. Invest Ophthalmol Vis Sci. 1995;36:718-729.
15. Holz FG, Sheraidah G, Pauleikhoff D, Bird AC. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch. Ophthalmol. 1994;112:402-406.
16. Holz FG, Bellmann C, Margaritidis M, Schütt F, Otto TP, Völcker HE. Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1999;237:145-152.
17. Eldred GE, Lasky MR. Retinal age-pigments generated by self-assembling lysosomotropic detergents. Nature. 1993;361:724-726.
18. Eldred GE. Age pigment structure. Nature. 1993;364:396.
19. Hayes KC, Lindsey S, Stephan ZF, Brecker D. Retinal pigment epithelium possesses both LDL and scavenger receptor activity Infest Ophthalmol Vis Sci. 1989;30:225-232.
20. Davis AA, Bernstein PS, Bok D, Turner J, Nachtigal M, Hunt RC. A human retinal pigment epithelial cell line that retains characteristics after prolonged culture. Infest Ophthalmol Vis Sci. 1995;36: 955-964.
21. Rudel L, Lee J, Morris M, Fetts J. Characterization of plasma lipoproteins separated and purified by agarose-column chromatography. Biochem J. 1974;139:89-95.
22. Storrie B, Madden FA. Isolation of subcellular organelles. Methods Enzymol. 1990;182:203-225.
23. Graham JM. Identification of subcellular fractions. In: Graham, JM, Higgins JA. eds. Methods in Molecular Biology. Totowa, NJ: Humana Press; 1993:1-18.
24. Kopitz, J, Arnold A, Meissner T, Cantz M. Protein catabolism in fibroblasts cultured from patients with mucolipidosis II and other lysosomal disorders. Biochem J. 1993;295:577-580.
25. Neufeld EF, Cantz M. The mucopolysaccharidoses studied in cell culture. In: Hers HG, van Hoof F, eds. Lysosomes and Storage Diseases. New York: Academic Press; 1973:261-275.
26. Seglen PO. Inhibitors of lysosomal function. Methods Enzymol. 1983;96:737-764.
27. Cantz M, Kresse H, Barton RW, Neufeld EF. Corrective factors for inborn errors of mucopolysaccharide metabolism. Methods Enzymol. 1972;28:884-887.
28. Haugland RP. Cell-Permeant Probes for Lysosomes and Other Acidic Organelles: Handbook of Fluorescent Probes and Research Chemicals. 6th ed. Eugene, OR: Molecular Probes; 1996:274-278.
29. Brizzee KR, Ordy JM. Cellular features, regional accumulation, and prospects of modification of age pigments in mammals. In: Sohal RS, ed. Age Pigments. Amsterdam: Elsevier; 1981:101-154.
30. Herman ER. Retinal pigment epithelium: lysosomal enzymes and aging. Br J Ophthalmol. 1994;78:82-83.
31. Spranger J. The systemic mucopolysaccharidoses. Erg Inn Med Kinderbeilk NF. 1972;32:165-265.
32. Kenyon KR. Ocular manifestations and pathology of systemic mucopolysaccharidoscs. Birth Defects Orig Artic Ser. 1976;12:133-153.
33. Boulton M, Dontsov A, Jarvis-Evans J, Ostrovsky M. Svistunenko D. Lipofuscin is a photoinducible free radical generator. J Photochem Photobiol B. 1993;19:201-204.
34. Gaillard ER, Atherton SJ, Eldred G, Dillon J. Photophysical studies on human retinal lipofuscin. Photochem Photobiol. 1995;61:448-452.
35. Feeney-Burns L, Herman ER, Kothman H. Lipofuscin of human retinal pigment epithelium. Am J Ophthalmol. 1980;90:783-791.
36. Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol. 1987;31:291-306.
37. Weiter JJ, Delori FC, Wing GL, Fitch KA. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci. 1986;27:145-152.
38. Lopez PF, Maumenee IH, de la Cruz Z, Green WR. Autosomal-dominant fundus flavimaculatus: clinicopathologic correlation. Ophthalmology. 1990;97:798-809.
39. Aguirre GD, Laties A. Pigment epithelial dystrophy in the dog. Exp Eye Res 1976;23:247-256.
40. Dorey CK, Wu G, Ebenstein D, Garsd A, Weiter JJ. Cell loss in the aging retina: relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci. 1989;30: 1691-1699.
41. Rückmann AV, Fitzke FW, Bird AC. Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci. 1997;38:478-486.